Fig. 3
From: Prognostic value of p16, p53, and pcna in sarcoma and an evaluation of immune infiltration
K-M survival curve. A Association between high expression levels of p16, p53, and pcna genes and 5-year overall survival in patients with sarcoma. B Association between elevated levels of p16, p53, and pcna gene expression and 5-year relapse-free survival (RFS) in patients with sarcoma. C Association between high expression levels of p16, p53, and pcna genes and 10-year overall survival in patients with sarcoma. D Association between elevated levels of p16, p53, and pcna gene expression and 10-year relapse-free survival in patients with sarcoma